Show simple item record

A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors

dc.contributor.authorYazici, Y.
dc.contributor.authorYazici, H.
dc.date.accessioned2021-03-03T17:54:06Z
dc.date.available2021-03-03T17:54:06Z
dc.date.issued2007
dc.identifier.citationYazici Y., Yazici H., "A survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors", ANNALS OF THE RHEUMATIC DISEASES, cilt.66, sa.1, ss.124-127, 2007
dc.identifier.issn0003-4967
dc.identifier.otherav_4c1c94e2-6cea-42be-ad8e-2d8cec1ed429
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/54559
dc.identifier.urihttps://doi.org/10.1136/ard.2006.055848
dc.description.abstractBackground: The adequacy of reporting the time element in adverse effects in articles on randomised clinical trials of cyclooxygenase-2 and tumour necrosis factor (TNF) a antagonists was surveyed.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleA survey of inclusion of the time element when reporting adverse effects in randomised controlled trials of cyclo-oxygenase-2 and tumour necrosis factor alpha inhibitors
dc.typeMakale
dc.relation.journalANNALS OF THE RHEUMATIC DISEASES
dc.contributor.department, ,
dc.identifier.volume66
dc.identifier.issue1
dc.identifier.startpage124
dc.identifier.endpage127
dc.contributor.firstauthorID181387


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record